PRD-101

N/A

Report date: 2026/02/09 20:01:27

Base Information

Drug NamePRD-101
Drug Alias NamePRD-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtivesCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmaResearch Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPharmaResearch Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A